4 article(s) from Gao, Yu
Scheme 1: Schematic diagram of the preparation of AB-LNPs.
Scheme 2: Synthesis of BDP. (a) 2,4-dimethylpyrrole, TFA, DCM, 25°C, 8 h; DDQ, DCM, 25 °C, 0.5 h; TEA, BF3·OEt...
Scheme 3: Preparation orders and appearance of different formed AB-LNPs. Method A: Au3+ was added to the pref...
Figure 1: The characterization of AB-LNPs. (a) Size distribution of Au-LNPs and AB-LNPs. Digital photo of AB-...
Figure 2: Photothermal properties of AB-LNPs. (a) Photothermal heating curves for AB-LNPs at different BDP co...
Figure 3: Stability and drug release properties of AB-LNPs. Changes of (a) particle size and (b) zeta potenti...
Figure 4: Cellular uptake of AB-LNPs. Cellular uptake efficiency of 4T1 cells treated with (a) AB-LNPs or (c)...
Figure 5: In vitro anti-proliferative activities of AB-LNPs with and without laser irradiation. (a) Cell viab...
Figure 1: (a) XRD pattern and (b) Raman spectrum of Co3O4 powder.
Figure 2: SEM images of Co3O4 powder magnified (a) 25,000 times and (b) 100,000 times. (c) TEM image of the Co...
Figure 3: Electrochemical properties of the Co3O4 electrodes. (a) The first to fifth cycle profiles measured ...
Figure 4: Flowchart of a solution combustion synthesis (SCS) of Co3O4 nanomaterial.
Figure 1: (A) The structure of diosgenin. (B) The structure of FZU-0021-194-P2. (C) X-ray crystallographic an...
Figure 2: In vitro anticancer activity of diosgenin (Di) and its derivative FZU-0021-194-P2 (P2). (A) The ant...
Figure 3: Preparation and characterization of Di phytosomes (DiP) and P2 phytosomes (P2P). (A) Schematic illu...
Figure 4: In vitro antiproliferative activity of blank lipid nanoparticle (P), DiP, and P2P. (A) The cytotoxi...
Figure 5: (A) Cell cycle analysis of A549 and PC9 cells after treated with DiP and P2P for 72 h. (B) Cell apo...
Figure 1: Schematic illustration of the preparation procedure for MCNs. MIF-loaded CNs were prepared by a con...
Figure 2: The influence of the preparation conditions including Cs concentration (A), Cs/MIF mass ratio (B), ...
Figure 3: FITR spectra of (A) MIF, (B) blank CNs, and (C) MCNs. The MCNs formulation showed the characteristi...
Figure 4: XRD spectra of (A) Cs, (B) blank CNs, (C) MIF, and (D) MCNs. The XRD analysis of MCNs showed the de...
Figure 5: (A) DLS measurements of (1) CNs and (2) MCNs. (B) AFM images of (1) CNs and (2) MCNs.
Figure 6: In vitro release profiles of MIF from MCNs at pH 2.5 and 7.4. The release of MIF from the dialysis ...
Figure 7: In vitro cytotoxicity of CNs, MIF and MCNs against A549 (A), Hela (B), RL95-2 (C), and HepG2 cells ...
Figure 8: In vivo plasma concentration vs time of different MIF formulations. Male SD rats were given a singl...